CONSUMER & MARKET INTELLIGENCE

GLP-1 medications are no longer just changing appetite. Household purchasing data increasingly show fewer packs, lower grocery spending and movement away from traditional indulgence categories. But the emerging market is more complicated than consumers simply buying less food. Spending is being redistributed toward protein, fresh foods, nutrition and smaller eating occasions.

Key Takeaways

• British households containing GLP-1 users spent approximately £418 less on groceries than comparable households, according to Worldpanel by Numerator research.
• U.S. evidence also shows lower overall grocery spending among GLP-1 households, alongside movement away from snacks and sugary drinks toward fresh and protein-rich foods.
• The commercial effect is better understood as redistribution of food spending, not simply destruction of demand.
• Smaller portions could create opportunities for premium, nutrient-dense products rather than automatically producing equivalent declines in category value.
• Household effects mean the addressable GLP-1-influenced market could be larger than the number of people actually taking medication.
• Treatment discontinuation matters. Research suggests purchasing behavior can partially move back toward baseline after consumers stop GLP-1 therapy.

The Grocery Basket Is Already Changing

For food companies trying to understand GLP-1 medications, one of the industry’s biggest questions is beginning to receive a measurable answer: what happens to the grocery basket when someone in the household starts taking them?

Research from Worldpanel by Numerator found that 6.3 percent of British households contained at least one GLP-1 user in 2026, up from 4.1 percent in 2025 and 2.3 percent in 2024, representing roughly 1.9 million British adults. Households containing a GLP-1 user spent approximately £418 less on groceries than comparable households, with an estimated £780 million reduction in spending and 299 million fewer grocery packs purchased.

The British numbers should not be applied automatically to North America, but U.S. evidence points in a similar direction. PwC reported in June that 21 percent of surveyed U.S. households included a current GLP-1 user, compared with 9 percent in January 2025, with household grocery spending among users down 5.5 percent.

Demand Is Being Redistributed, Not Destroyed

The composition of the U.S. decline is revealing. Among current users surveyed by PwC, 61 percent reported purchasing fewer sweet treats and 56 percent fewer salty snacks, while 44 percent reported buying more fresh produce, 35 percent more packaged protein and 34 percent more fresh protein. McKinsey’s 2026 North American grocery research similarly found GLP-1 households moving away from indulgent products and toward fresh and protein-forward categories.

This distinction could become strategically important. A consumer may purchase fewer calories while simultaneously becoming willing to spend more per eating occasion on foods perceived as nutritionally valuable. Boston Consulting Group found active GLP-1 users expected to increase monthly spending on fruits and vegetables by 15 percent and high-protein foods by 11 percent, while reducing spending on candy by 14 percent and other indulgence categories by roughly 10 percent. Research released September 1 by the National Frozen & Refrigerated Foods Association reinforces the point: 52 percent of surveyed GLP-1 users reported buying more high-protein dairy, and 48 percent more single-serve or portion-controlled foods.

Pack Architecture May Need to Change

For decades, packaged-food economics have often rewarded larger packs, higher consumption frequency and value messaging based on quantity. GLP-1 challenges parts of that model. If consumers increasingly want smaller portions while prioritizing protein, fiber, nutrient density and convenience, manufacturers may need to rethink what constitutes value.

A smaller package does not necessarily need to be a cheaper one. Premium single portions, nutrient-dense snacks, protein-forward frozen meals and products engineered around satisfaction rather than volume could allow manufacturers to protect value while selling fewer physical units. That strategy will not work universally, and GLP-1 users are not a homogeneous segment, but treating portion reduction purely as lost volume risks overlooking the possibility of premiumization around nutritional efficiency.

The Effect Extends Beyond the User, and May Not Be Permanent

Manufacturers should avoid measuring this market solely by prescriptions. Household purchasing data capture something prescription statistics cannot: food is frequently purchased and consumed collectively, so when one household member changes meal size or snacking habits, other people may eat differently too. That means the commercial footprint of GLP-1 medications could extend beyond active users.

At the same time, behavior may not remain constant. A peer-reviewed study in the Journal of Marketing Research found grocery spending declined after GLP-1 adoption, with particularly strong reductions in calorie-dense processed categories, savory-snack spending down 10.1 percent, while yogurt moved in the opposite direction. Importantly, households discontinuing treatment began moving back toward their previous purchasing patterns. The GLP-1 consumer is not necessarily a permanent consumer state, which complicates long-term forecasting.

The strategic question facing food companies is evolving. It is no longer simply how much less GLP-1 consumers will eat. It is where they will spend the money that remains in the grocery basket. Answering that may determine which categories lose volume and which companies capture the new economics of eating.

Related on GFI: New GLP-1 Data Is Overturning the Food Industry’s Favorite Assumptions and GLP-1 Is Not Killing the Food Industry.

---

Sources

1. Worldpanel by Numerator. Research reported June 10, 2026, covering more than 11,500 British households and GLP-1-related grocery purchasing.
2. PwC. The end of more: How GLP-1 users shop, eat, and seek support. June 22, 2026.
3. McKinsey & Company. The State of Grocery in North America 2026.
4. Boston Consulting Group. GLP-1s Are Reshaping Consumer Behavior in 2026. August 2026.
5. National Frozen & Refrigerated Foods Association. New Research: GLP-1 Users Reshaping the Grocery Basket. September 1, 2026.
6. Hristakeva S., Liaukonytė J., Feler L. The No-Hunger Games: How GLP-1 Medication Adoption Is Changing Consumer Food Demand. Journal of Marketing Research, 2026;63(3):427-444.
7. Circana. GLP-1 Consumer Behavior. Consumer purchasing and category analysis.